Zobrazeno 1 - 10
of 19
pro vyhledávání: '"D C, Montefiori"'
Autor:
E. I. M. M. Reiss, M. M. van Haaren, J. van Schooten, M. A. F. Claireaux, P. Maisonnasse, A. Antanasijevic, J. D. Allen, I. Bontjer, J. L. Torres, W-H Lee, G. Ozorowski, N. Vázquez Bernat, M. Kaduk, Y. Aldon, J. A. Burger, H. Chawla, A. Aartse, M. Tolazzi, H. Gao, P. Mundsperger, M. Crispin, D. C. Montefiori, G. B. Karlsson Hedestam, G. Scarlatti, A. B. Ward, R. Le Grand, R. Shattock, N. Dereuddre-Bosquet, R. W. Sanders, M. J. van Gils
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-13 (2022)
Abstract The HIV-1 envelope glycoprotein (Env) trimer is the key target for vaccines aimed at inducing neutralizing antibodies (NAbs) against HIV-1. The clinical candidate immunogen ConM SOSIP.v7 is a stabilized native-like HIV-1 Env trimer based on
Externí odkaz:
https://doaj.org/article/d919d26129cb4d55a6a5afbc08a9a26e
Publikováno v:
Journal of Clinical Investigation. 92:840-847
Sera from 11 volunteers immunized with a recombinant HIV-1 gp160-expressing vaccinia virus (HIVAC-1e; Oncogen/Bristol-Myers Squibb, Seattle, WA) and boosted with baculovirus-derived rgp160 (VaxSyn; MicroGeneSys, Inc., Meriden, CT) were evaluated for
Autor:
E, O'Neill, I, Martinez, F, Villinger, M, Rivera, S, Gascot, C, Colon, T, Arana, M, Sidhu, R, Stout, D C, Montefiori, M, Martinez, A A, Ansari, Z R, Israel, E, Kraiselburd
Publikováno v:
Journal of medical primatology. 31(4-5)
The ever increasing number of people infected by human immunodeficiency virus (HIV) throughout the world renders the development of effective vaccines an urgent priority. Herein, we report on an attempt to induce and enhance antiviral responses using
Autor:
R, Hofmann-Lehmann, J, Vlasak, R A, Rasmussen, S, Jiang, P L, Li, T W, Baba, D C, Montefiori, B J, Bernacky, T A, Rizvi, R, Schmidt, L R, Hill, M E, Keeling, H, Katinger, G, Stiegler, L A, Cavacini, M R, Posner, R M, Ruprecht
Publikováno v:
Journal of medical primatology. 31(3)
Simian-human immunodeficiency viruses (SHIV) allow the evaluation of antiviral strategies that target the envelope glycoproteins of the human immunodeficiency virus 1 (HIV-1) in macaques. We previously protected neonates from oral challenge with cell
Autor:
Robert A, Rasmussen, R, Hofmann-Lehman, D C, Montefiori, P L, Li, V, Liska, J, Vlasak, T W, Baba, J E, Schmitz, M J, Kuroda, H L, Robinson, H M, McClure, S, Lu, S L, Hu, T A, Rizvi, R M, Ruprecht
Publikováno v:
Journal of medical primatology. 31(1)
Newborn macaques were vaccinated against a chimeric simian human immunodeficiency (SHIV) virus, SHIV-vpu+, by DNA priming and boosting with homologous HIV-1 gp160. Following SHIV-vpu+ challenge, containment of infection was observed in 4 of 15 animal
Publikováno v:
Developments in biologicals. 104
Eight different protocols for immunization have been compared for the ability to raise protection against immunodeficiency virus challenges in rhesus macaques. The most promising containment of challenge infections was achieved by intradermal DNA pri
Autor:
B S, Graham, M J, McElrath, R I, Connor, D H, Schwartz, G J, Gorse, M C, Keefer, M J, Mulligan, T J, Matthews, S M, Wolinsky, D C, Montefiori, S H, Vermund, J S, Lambert, L, Corey, R B, Belshe, R, Dolin, P F, Wright, B T, Korber, M C, Wolff, P E, Fast
Publikováno v:
The Journal of infectious diseases. 177(2)
Among 2099 uninfected subjects in phase I and II trials of candidate AIDS vaccines, 23 were diagnosed with intercurrent human immunodeficiency virus type 1 (HIV-1) infection. High-risk sexual exposures accounted for 17 infections, and intravenous dru
Autor:
S, Lu, R, Wyatt, J F, Richmond, F, Mustafa, S, Wang, J, Weng, D C, Montefiori, J, Sodroski, H L, Robinson
Publikováno v:
AIDS research and human retroviruses. 14(2)
DNA vaccines that express the human immunodeficiency virus type 1 HXB-2 envelope glycoprotein (Env) with or without deletions of the major variable regions V1/V2 and V3 were tested for the ability to raise enzyme-linked immunosorbent assay (ELISA) an
Autor:
D R, Burton, D C, Montefiori
Publikováno v:
AIDS (London, England). 11
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 157(12)
Variants of SIV containing a deletion in the nef gene are attenuated in adult macaques, where they provide protection from challenge with pathogenic SIV, but the mechanism of protection remains unknown. One of these attenuated variants carrying delet